Targeted Complement Inhibition with Homodimeric Minimal Factor H During Porcine Normothermic Machine Perfusion Attenuates Renal Ischemia-Reperfusion Injury
Background: The alternative pathway (AP) of complement activation is a key driver in the pathogenesis of ischaemia-reperfusion injury (IRI). Factor H (FH) acts as the principal regulator of the AP. This study evaluates the efficacy of a novel homodimeric minimal FH (HDM-FH) construct (previously shown to control the AP in several mouse models) within a high-fidelity, ex-vivo human-relevant model of renal injury. Methods: In a randomised study, 5 mg of HDM-FH was administered during 6-hour autologous whole blood-based normothermic machine perfusion (NMP) of porcine kidney pairs recovered following circulatory death. Renal physiology, markers of complement activation (soluble (s)C5b-9, tissue Bb, and C1q deposits), immune cell infiltration (neutrophils, macrophages, and T-cells), glycocalyx shedding, and markers of cell death were assessed and compared against controls. Results: HDM-FH administration resulted in no adverse effects on renal physiology. Treatment significantly reduced complement activation, evidenced by decreased sC5b-9 in perfusate (p=.048) and urine (p=.031), as well as reduced tissue deposits of Bb (p=.009) and intriguingly, C1q (p=.005). This inhibition correlated with a significant reduction in immune cell infiltration, including neutrophils (p=.015), macrophages (p=.021), and T-cells (p=.04). Furthermore, downstream indicators of IRI were improved, with attenuated glycocalyx shedding (p=.028) and reduced cell death (p=.001) at the conclusion of NMP. Conclusions: These findings demonstrate that HDM-FH effectively controls complement activation during IRI in a human-relevant model. By blocking the immunopathological cascade, localized real-time complement inhibition provides significant downstream benefits in reducing immune infiltration and cellular injury. Therefore, HDM-FH holds therapeutic potential for mitigating complement-mediated injury following transplantation.
Authors
- Harriet Denton
- Kevin J. Marchbank (ORCID: https://orcid.org/0000-0003-1312-5411)
- Rolando Berlinguer‐Palmini (ORCID: https://orcid.org/0000-0002-1786-496X)
- Neil Sheerin
- Lucy Bates
- Madison Cooper
- Beth Gibson
- Chloe Connelly
- Tom-Erik Mollnes
- Yi Yang
- Min Wu
- Emily Thompson
- Kirstin Pettersen
- Georgios Kourounis
- Samuel Tingle
- Balaji Mahendran
- Colin Wilson
Publication Details
- Journal
- Newcastle University ePrints (Newcastle Univesity)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.25405/ncl.35023732
- Primary Topic
- Complement system in diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00